Open AccessRadiotherapy concurrent with weekly gemcitabine after transurethral tumor resection in muscle ınvasive bladder cancer
Author(s) -
Umut Demirci,
Ömer Dizdar,
Mehmet Faik Çetindağ,
Serkan Altınova,
Atiye Yılmaz Özsavran,
Didem Şener Dede,
Nurgul Kızılırmak,
Fatma Aysun Eraslan,
Bülent Yalçın,
Havva Yeşil Çınkır
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.147381
Subject(s) - gemcitabine , medicine , resection , bladder cancer , chemo radiotherapy , radiation therapy , urology , oncology , cancer , surgery
In this report, we determined the efficacy and the toxicity of low dose weekly gemcitabine with radiotherapy, in medically unfit or refused surgery muscle-invasive bladder cancer (BC) patients.